These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 27239049)

  • 1. White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
    Bergsland N; Tavazzi E; Laganà MM; Baglio F; Cecconi P; Viotti S; Zivadinov R; Baselli G; Rovaris M
    J Neuroimaging; 2017 Jan; 27(1):107-113. PubMed ID: 27239049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
    Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
    Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis.
    Weeda MM; van Nederpelt DR; Twisk JWR; Brouwer I; Kuijer JPA; van Dam M; Hulst HE; Killestein J; Barkhof F; Vrenken H; Pouwels PJW
    J Neurol; 2024 Jan; 271(1):355-373. PubMed ID: 37716917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between iron accumulation and white matter injury in multiple sclerosis: a case-control study.
    Raz E; Branson B; Jensen JH; Bester M; Babb JS; Herbert J; Grossman RI; Inglese M
    J Neurol; 2015 Feb; 262(2):402-9. PubMed ID: 25416468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
    J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
    Moccia M; Quarantelli M; Lanzillo R; Cocozza S; Carotenuto A; Carotenuto B; Alfano B; Prinster A; Triassi M; Nardone A; Palladino R; Brunetti A; Brescia Morra V
    Eur J Neurol; 2017 Jan; 24(1):195-204. PubMed ID: 27801535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
    Ma AY; Vitorino RC; Hojjat SP; Mulholland AD; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
    Mult Scler; 2017 Dec; 23(14):1884-1892. PubMed ID: 28178867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis.
    Caporale AS; Chiarelli AM; Biondetti E; Villani A; Lipp I; Di Censo D; Tomassini V; Wise RG
    Hum Brain Mapp; 2024 Jun; 45(9):e26761. PubMed ID: 38895882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.
    Preziosa P; Pagani E; Meani A; Marchesi O; Conti L; Falini A; Rocca MA; Filippi M
    J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex.
    Tedone N; Preziosa P; Meani A; Pagani E; Vizzino C; Filippi M; Rocca MA
    Mol Psychiatry; 2023 Apr; 28(4):1783-1792. PubMed ID: 36806391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
    Futatsuya K; Kakeda S; Yoneda T; Ueda I; Watanabe K; Moriya J; Murakami Y; Ide S; Ogasawara A; Ohnari N; Okada K; Adachi H; Korogi Y
    Magn Reson Med Sci; 2016 Oct; 15(4):349-354. PubMed ID: 26841855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
    Chen W; Zhang Y; Mu K; Pan C; Gauthier SA; Zhu W; Wang Y
    AJR Am J Roentgenol; 2017 Oct; 209(4):889-894. PubMed ID: 28705068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White and gray matter damage in primary progressive MS: The chicken or the egg?
    Bodini B; Chard D; Altmann DR; Tozer D; Miller DH; Thompson AJ; Wheeler-Kingshott C; Ciccarelli O
    Neurology; 2016 Jan; 86(2):170-6. PubMed ID: 26674332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.
    Mulholland AD; Vitorino R; Hojjat SP; Ma AY; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):91-96. PubMed ID: 29097413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.